Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
BERLIN (dpa-AFX) - Das Alzheimer-Medikament Donanemab (Handelsname Kisunla) ist ab sofort in Deutschland verfügbar. Nur wenige…
INDIANAPOLIS/KATWIJK (dpa-AFX) - Der US-Pharmakonzern Lilly stockt seine Kapazitäten in Europa auf. Lilly plant den…
Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand…
…
…
The drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications…
The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a…
These are some of the stocks posting the largest moves in early trading.…
Eli Lilly raised its full-year profit and revenue forecasts on Thursday as strong appetite for its widely popular weight-loss and…
Eli Lilly and Co (NYSE:LLY) on Thursday reported third quarter 2025 financial results that handily beat Wall Street forecasts, as the company…
Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailers locations or…
As obesity drug heavyweights Eli Lilly and Novo Nordisk gear up to release results for the third quarter, investors are…
Eli Lilly steht kurz vor einem der größten Produktstarts seiner Geschichte. Der Pharmakonzern aus Indianapolis hat bereits Milliarden Dosen seiner…
On October 27, 2025, Eli Lilly announced that the U.S. FDA approved a new, once-monthly single-injection maintenance regimen of Omvoh…
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Its the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten…
Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and…
Lillys stock has pulled back from its 2024 highs, but that doesnt mean the shares are cheap enough to buy.…
Eli Lillys Q3 results hinge on strong demand for Mounjaro and Zepbound as investors weigh growth drivers against the pressure…
Long-term investors dont need to rush to buy Eli Lilly stock.…
…
…
Key PointsSold 6,430 shares of Eli Lilly and Company; estimated transaction value ~$4.78 millionPost-trade holding: 61,292 shares valued at $46.77…
The rapid growth rates of recent years arent guaranteed to continue.…
Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely…
Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely…
Key PointsIncreased position by 259,392 shares in Q3 2025; estimated $193.03 million trade based on the average price during Q3…
Novo Nordisk and Eli Lilly shares fell after President Donald Trump said the price of the blockbuster diabetes drug Ozempic could come down to just…
Eli Lilly and Novo Nordisk shares dropped after President Donald Trump said he wants a $150 price tag for GLP-1s.…
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments introduced significant uncertainty…
Trumps pledge to slash GLP-1 drug prices sends Novo Nordisk and Eli Lilly shares tumbling, raising questions about the feasibility…
Trump’s comments on Ozempic “signal aggressive posturing” in drug price negotiations, an analyst said…
American Express, Truist Financial and Fifth Third rise premarket; Eli Lilly falls…
Cantor Fitzgerald maintains Eli Lilly stock rating despite orforglipron setback…
US equity futures decline, Treasuries extend rally and the dollar stays on track for its biggest weekly drop since July.…
Shares of Novo Nordisk (NYSE:NVO) and Eli Lilly and Co (NYSE:LLY), two major pharmaceutical companies that produce weight-loss drugs, dropped…
These stocks have climbed in the triple digits over the past few years.…
Shares of Eli Lilly and Novo Nordisk move lower in Thursdays after-hours session after President Trump indicated weight-loss drugs are…
Key PointsChesapeake sold 9,875 Eli Lilly and Company shares; estimated trade value of approximately $7.68 million, based on the average…
The smaller drugmaker is looking to disrupt a fast-growing market.…
Eli Lilly (LLY) concluded the recent trading session at $826.57, signifying a +1.75% move from its prior days close.…
…
Strong sector performers stand out as AAPL, LLY, and V gain traction through services, drug demand, and digital payment growth.…
Apples strong Services growth, Eli Lillys GLP-1 momentum, and Visas digital expansion headline todays top stock reports.…
…
The company is readying to take on pharma giants Novo Nordisk and Eli Lilly.…
Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after…
The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo…
Eli Lilly (LLY) reached $855.35 at the closing of the latest trading day, reflecting a +1.14% change compared to its…